[ about the client/ ]
Novo Nordisk is a global pharmaceutical company focused on chronic conditions such as diabetes, obesity, hemophilia, and growth disorders. Its U.S. Market Access team relied on large volumes of insurance and healthcare data to support account planning, payer strategy, and regional market access initiatives.
The challenge was that much of this data was costly, complex, and hard for account teams to use in daily planning. MEV built MEDIX, a custom CRM platform that used data engineering and NLP to turn unstructured insurance data into actionable insights for 2,000+ sales and market access users.